Moreover, in vitro studies in post-MI-rodents, reported that increased cardiac FGF23 expression drives cardiac fibrosis via activation of β-catenin which is a well-known pro-fibrotic factor that interacts with TGF- β signaling [30]. This evidence concerns the gene FGF23 and myocardial infarction.